MBX Biosciences, Inc. Common Stock (MBX) NASDAQ
30.05
-0.65(-2.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.05
-0.65(-2.12%)
Currency In USD
| Market Cap | 1.15B |
| Enterprise Value | 1.08B |
| P/E Ratio | -16.16 |
| PEG Ratio | 14.39 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.2 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.19 |
| Return On Equity | -0.25 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -248,000 |
| EBITDA | -98.06M |
| Net Income | -86.97M |
| Diluted EPS | -2.38 |
| Total Cash | 439.98M |
| Total Cash/Share | 9.45 |
| Total Debt | 555,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 30.79 |
| Book Value Per Share | 9.4 |
| 52-Week Change | 120.31 |
| 52-Week High | 45.85 |
| 52-Week Low | 9.43 |
| Moving Average 50 Days | 31.92 |
| Moving Average 200 Days | 27.35 |
| Average Volume | 570,601 |
| Shares Outstanding | 33.59M |
| % Held by Institutions | 143.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |